[Methoxy polyethylene glycol-epoetin beta (Mircera) in the treatment of a patient with chronic kidney disease presenting late-onset hypersensitivity to other epoetins]

Nefrologia. 2010;30(3):372-3. doi: 10.3265/Nefrologia.pre2010.Mar.10310.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • Chronic Disease
  • Drug Hypersensitivity / etiology*
  • Drug Hypersensitivity / prevention & control
  • Erythropoietin / administration & dosage
  • Erythropoietin / adverse effects*
  • Erythropoietin / therapeutic use*
  • Female
  • Humans
  • Hypersensitivity, Delayed / chemically induced*
  • Hypersensitivity, Delayed / prevention & control
  • Injections, Subcutaneous
  • Kidney Diseases / blood
  • Kidney Diseases / complications*
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins

Substances

  • Recombinant Proteins
  • continuous erythropoietin receptor activator
  • epoetin beta
  • Erythropoietin
  • Polyethylene Glycols